Development and Validation of a Simple and Sensitive ICP-MS Method for the Quantification of Elemental Impurities in Propafenone Hydrochloride Drug Substance
DOI:
https://doi.org/10.35516/jjps.v16i2.364Keywords:
Elemental Impurities, ICP-MS, Propafenone Hydrochloride, ValidationAbstract
Elemental impurities are substances present in drug products, excipients, or drug formulations. They may be formed by the presence of catalysts and environmental contaminants. Elemental impurities can be detected by a sophisticated method such as Inductively Coupled Plasma Mass Spectrometry (ICP–MS). ICP-MS is an advanced method to detect elemental impurities in drug substances. In this study Propafenone hydrochloride drug was used, Propafenone Hydrochloride is an antiarrhythmic medication belonging to class 1C used to prevent supraventricular and ventricular arrhythmias. The present study was aimed to develop and validate inductively coupled plasma mass spectroscopic (ICP–MS) method for detection of elemental contaminants, i.e., Class 1, Cd, Pb, As, Class 2A, Hg, Co, V, and Class 2B impurities such as Ni, T1, Se, Ag, Au, Pd, Ir, Os, Rh, Ru, and Pt. Total 17 elemental impurities were detected in Propafenone Hydrochloride and this method was employed for the regular sample analysis of 17 elemental impurities in Propafenone Hydrochloride for pharmaceutical use. The instrument conditions were set using RF power of 1550 W, auxiliary gas of 0.5 L/min, and nebulizer flow of 1.01 L/min nebulizer pump pressure was 0.10 rps, spray chamber temperature was 2°C, and mode used was He, He flow rate was 4.3 mL/min and the energy discrimination rate was 3.0 V. The technique is sensitive and may identify desirable elemental impurities within permissible regulatory limits when additional elements are present. The proposed ICP-MS approach has been found to be accurate, precise, linear, rugged, robust, and convenient for the quality control of the drug substance propafenone hydrochloride. The linearity results for each impurity were 0.9990. The methods were validated according to USP requirements and International Council for Harmonization ICH guidelines. The suggested approach is an excellent quality control tool for the concurrent quantitative assessment and detection of elemental contaminants at low levels in the drug substance propafenone hydrochloride.
References
G. Li, D. Schoneker, K. L. Ulman, J. J. Sturm, L. M. Thackery, and J. F. Kauffman, “Elemental Impurities in Pharmaceutical Excipients,” J. Pharm. Sci., vol. 104, no. 12, pp. 4197–4206, 2015, doi:
https://doi.org/10.1002/jps.24650.
W. Yong-jiang, M. Ming-ming, and Z. Su, “Enantioselective assay of S(+)- and R(-)-propafenone in human urine by using RP-HPLC with pre-column chiral derivatization,” J. Zhejiang Univ. A, vol. 5, no. 2, pp. 226–229, 2004, doi: 10.1007/BF02840928.
Barin JS, Mello PA, Mesko MF, Duarte FA, Flores EM. Determination of elemental impurities in pharmaceutical products and related matrices by ICP-based methods: a review. Anal Bioanal Chem. 2016;408(17):4547-4566. doi:10.1007/s00216-016-9471-6
Janchevska K, Stafilov T, Memed-Sejfulah S, Bogdanoska M, Ugarkovic S, Petrushevski G. ICH Q3D based elemental impurities study in liquid pharmaceutical dosage form with high daily intake - comparative analysis by ICP-OES and ICP-MS. Drug Dev Ind Pharm. 2020;46(3):456-461. doi:10.1080/03639045.2020.1724136
Muller AL, Oliveira JS, Mello PA, Muller EI, Flores EM. Study and determination of elemental impurities by ICP-MS in active pharmaceutical ingredients using single reaction chamber digestion in compliance with USP requirements. Talanta. 2015;136:161-169.
doi: 10.1016/j.talanta.2014.12.023
S. C. Wilschefski and M. R. Baxter, “Inductively Coupled Plasma Mass Spectrometry: Introduction to Analytical Aspects.,” Clin. Biochem. Rev., vol. 40, no. 3, pp. 115–133, Aug. 2019, doi: 10.33176/AACB-19-00024.
O. Chahrour et al., “Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP 〈232〉/〈233〉,” J. Pharm. Biomed. Anal., vol. 145, pp. 84–90, 2017, doi: https://doi.org/10.1016/j.jpba.2017.06.045.
United States Pharmacopeia (2008) Ad hoc advisory panel on inorganic impurities and heavy metals and USP staff—stimuli to the revision process: general chapter on inorganic impurities: heavy metals.
The United States Pharmacopeia Convention (2013), The United States pharmacopeia, Chapter 232: Elemental Impurities – Limits
Pluháček T, Ručka M, Maier V. A direct LA-ICP-MS screening of elemental impurities in pharmaceutical products in compliance with USP and ICH-Q3D. Anal Chim Acta. 2019 Oct 31;1078:1-7. doi: 10.1016/j.aca.2019.06.004.
Shirayama Y, Doki K, Sekiguchi Y, Aonuma K, Kohda Y, Homma M. Simultaneous determination of serum propafenone and its metabolites using high-performance liquid chromatography. Biomed Chromatogr. 2018 Feb;32(2). doi: 10.1002/bmc.4099.
Wang Y, Zhong D, Chen R. [A reversed phase HPLC method with pre-column derivatization to determine propafenone enantiomers in human plasma]. Yao Xue Xue Bao. 1998;33(2):138-42.
Nageswara Rao R, Madhuri D, Siva Sankar Reddy L, Tejeswini P Propafenone HCl in pure drug and its tablet dosage form by RP-HPLC Int. J. Res. Pharm. Sci., 2018, 9(3): 656-662
Sagar Suman Panda, B.V.V. Ravi Kumar, Sasmita Kumari Acharjya and Kalyani Sahu RP-UFLC Method for Estimation of Propafenone in Tablets nternational Journal of Pharmaceutical Sciences and Nanotechnology, 2014, 7(4): 2671-2676.
Gupta, R. K.; Chaurasia, A.; Mishra, B. Simultaneous estimation of Propafenone and its two metabolites in human plasma by Liquid Chromatography Tandem Mass Spectrometry LC-MS/MS. Int J Pharm Pharm Sci 2017, 9, 192-199.
Sujan Kumar D. P. , Palavan C. and Seshagiri Rao J. V. L. N. A rapid and sensitive LC–MS/MS assay for the determination of propafenone and its active metabolite 5–hydroxy propafenone in human plasma using hybrid SPE precipitation technology Der Pharmacia Lettre, 2015, 7 (4):122-128
M. L. Jadhav and S. R. Tambe, “Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Propafenone Hydrochloride in Tablet Dosage Form,” Chromatogr. Res. Int., vol. 2013, p. 676501, 2013, doi: 10.1155/2013/676501.
Z. Chi, R. Liu, Y. Li, K. Wang, C. Shu, and L. Ding, “A Sensitive and Rapid LC–MS-MS Method for Simultaneous Determination of Propafenone and Its Active Metabolite 5-Hydroxypropafenone in Human Plasma and Its Application in a Pharmacokinetic Study,” J. Chromatogr. Sci., vol. 55, no. 9, pp. 911–917, 2017, doi: 10.1093/chromsci/bmx049.
F. C. Pinheiro, M. Á. Aguirre, J. A. Nóbrega, N. González-Gallardo, D. J. Ramón, and A. Canals, “Dispersive liquid-liquid microextraction based on deep eutectic solvent for elemental impurities determination in oral and parenteral drugs by inductively coupled plasma optical emission spectrometry,” Anal. Chim. Acta, vol. 1185, p. 339052, 2021, doi: https://doi.org/10.1016/j.aca.2021.339052.
W. Pretorius, D. Chipley, K. Kyser, and H. Helmstaedt, “Direct determination of trace levels of Os{,} Ir{,} Ru{,} Pt and Re in kimberlite and other geological materials using HR-ICP-MS,” J. Anal. At. Spectrom., vol. 18, no. 4, pp. 302–309, 2003, doi: 10.1039/B208185G.
D. A. Armbruster and T. Pry, “Limit of blank, limit of detection and limit of quantitation.,” Clin. Biochem. Rev., vol. 29 Suppl 1, no. Suppl 1, pp. S49-52, Aug. 2008.
F. G. Antes, M. F. Mesko, J. S. Barin, C. M. Moreira, É. M. M. Flores, and V. L. Dressler, “Development of multi-elemental method for quality control of parenteral component solutions using ICP-MS,” Microchem. J., vol. 98, no. 1, pp. 144–149, 2011, doi: https://doi.org/10.1016/j.microc.2010.12.010.
K. Jancevska, G. Petrushevski, M. Bogdanoska, T. Stafilov, and S. Ugarkovic, “ICP-OES elemental impurities study on different pharmaceutical dosage forms of Ibuprofen using microwave-assisted digestion procedure,” Maced. J. Chem. Chem. Eng., vol. 40, no. 1, pp. 43–50, May 2021, doi: 10.20450/mjcce.2021.2100.
O. Geiss et al., “Determination of the Transport Efficiency in spICP-MS Analysis Using Conventional Sample Introduction Systems: An Interlaboratory Comparison Study,” Nanomaterials, vol. 12, no. 4, 2022, doi: 10.3390/nano12040725.
M. Aramendía et al., “A novel approach for adapting the standard addition method to single particle-ICP-MS for the accurate determination of NP size and number concentration in complex matrices,” Anal. Chim. Acta, vol. 1205, p. 339738, 2022, doi: https://doi.org/10.1016/j.aca.2022.339738.
K. V Merusomayajula, S. R. Tirukkovalluri, R. S. Kommula, S. V. Chakkirala, J. K. Vundavilli, and P. K. S. R. Kottapalli, “Development and validation of a simple and rapid ICP-OES method for quantification of elemental impurities in voriconazole drug substance,” Futur. J. Pharm. Sci., vol. 7, no. 1, p. 45, 2021, doi: 10.1186/s43094-020-00159-2.
Al-Hakkani, M.F. Guideline of inductively coupled plasma mass spectrometry “ICP–MS”: fundamentals, practices, determination of the limits, quality control, and method validation parameters. SN Appl. Sci. 1, 791 (2019). https://doi.org/10.1007/s42452-019-0825-5.
Alzweiri, M.; Sweidan, K.; Aqel, Q. Investigation of the Chemical Stability of Lenalidomide in Methanol/Ethanol Solvents Using RP-HPLC-UV and LC-MS. Jordan J. Pharm. Sci., 2022, 15, 305-314.
Sonawane, S. S.; Joshi, G. J.; Kshirsagar, S. J. Development and Validation of HPLC Method for Quantification of Zonisamide in Spiked Human Plasma. Jordan J. Pharm. Sci., 2022, 15, 40-50.
